ACTIVE

PHARMACIE BEAUPORT

Export PDF

Financial year 2025 · Closed on 31/12/2025

Net result53,5 k €+225,0 %over 1 year
Gross margin144,6 k €+65,3 %over 1 year
Equity472,6 k €+12,8 %over 1 year
Workforce1,8 ETP+20,0 %over 1 year

Identity

Source · BCE/KBO

PHARMACIE BEAUPORT is a Private company with limited liability incorporated in 2010. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Ixelles. It employs on average 1,8 ETP workers (FTE).

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0831.183.694
Incorporation
18/11/2010
Legal form
Private company with limited liability
Registered office
Place Georges Brugmann 9
1050 Ixelles · BruxellesSee on map
Contributed capital
25 000,00 €
Latest accounts
31/12/2025
Average workforce
1,8 ETP
Joint committees (1)
  • 313
Contacts
1 public detail availableLog in to view
Signals
ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debts

Financials

Source · NBB, 15 filings

Trend over 15 financial years

20252024202320222021
Income statement
Gross margin144,6 k €87,5 k €124,7 k €207,8 k €244,4 k €
EBITDA66,5 k €-36,1 k €22,1 k €102,1 k €144 k €
Operating result60,6 k €-41,1 k €20,7 k €100,3 k €141,4 k €
Net result53,5 k €-42,8 k €10,9 k €78,8 k €108,6 k €
Balance sheet
Equity472,6 k €419,1 k €461,9 k €451 k €372,2 k €
Total assets584,7 k €522,9 k €621,1 k €528,9 k €474,5 k €
Cash163,9 k €110,4 k €129 k €135 k €221,3 k €
Debts112,1 k €103,8 k €158,3 k €77,9 k €102,1 k €
Other
Workforce1,8 ETP1,5 ETP1,9 ETP1,7 ETP–

Valuation

Indicative valuation

As an indication, this company is worth

between 500 k€ and 1 M€
See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

1 active · 4 ended

Active mandates

PharmaLEDA

Director · 0792.415.863

Represented by Kenza EL OUARIACHI

Active

Ended mandates

PharmaLEDA

Director · since 01 avril 2023 · 0792.415.863

Represented by Kenza EL OUARIACHI

Ended
Aliette Beauport

Director · since 17 novembre 2010

Ended
Aliette Beauport

Manager · since 17 novembre 2010

Ended
Aliette BEAUPORT

Manager

Ended

Full financial information

Source · NBB
202520242023202220212020
Type of accountAbridged modelAbridged modelAbridged modelAbridged modelMicro modelMicro model
Start of the financial year01/01/202501/01/202401/01/202301/01/202201/01/202101/01/2020
Closing of the financial year31/12/202531/12/202431/12/202331/12/202231/12/202131/12/2020
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date06/07/202604/07/202516/08/202405/07/202304/07/202231/08/2021
General meeting13/06/202613/06/202513/06/202431/03/202313/06/202214/06/2021
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 15 filings
ModelClosingGeneral meetingFiledLanguageDocument
Abridged model31/12/202513/06/202606/07/2026FrenchPDF
Abridged model31/12/202413/06/202504/07/2025FrenchPDF
Abridged model31/12/202313/06/202416/08/2024FrenchPDF
Abridged model31/12/202231/03/202305/07/2023FrenchPDF
Micro model31/12/202113/06/202204/07/2022FrenchPDF
Micro model31/12/202014/06/202131/08/2021FrenchPDF
Micro model31/12/201913/06/202029/06/2020FrenchPDF
Micro model31/12/201813/06/201917/06/2019FrenchPDF
Abridged model31/12/201713/06/201824/07/2018FrenchPDF
Abridged model31/12/201613/06/201709/08/2017FrenchPDF
Abridged model31/12/201513/06/201601/08/2016FrenchPDF
Abridged model31/12/201413/06/201516/07/2015FrenchPDF
Abridged model31/12/201313/06/201416/09/2014FrenchPDF
Abridged model31/12/201213/06/201312/07/2013FrenchPDF
Abridged model31/12/201113/06/201220/06/2012FrenchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 500 k€ and 1 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

1 active · 4 ended

Active mandates

PharmaLEDA

Director · 0792.415.863

Represented by Kenza EL OUARIACHI

Active

Ended mandates

PharmaLEDA

Director · since 01 avril 2023 · 0792.415.863

Represented by Kenza EL OUARIACHI

Ended
Aliette Beauport

Director · since 17 novembre 2010

Ended
Aliette Beauport

Manager · since 17 novembre 2010

Ended
Aliette BEAUPORT

Manager

Ended

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Mandates10/05/2023
    DEMISSIONS, NOMINATIONS
    PDF
  • Registered office30/04/2014
    SIEGE SOCIAL
    PDF
  • Capital / shares07/03/2011
    CAPITAL, ACTIONS - DIVERS
    PDF
  • Other29/11/2010
    RUBRIQUE CONSTITUTION (NOUVELLE PERSONNE MORALE, OUVERTURE SUCCURSALE, ETC...)
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 202553,5 k €↑
  2. 2024
    Annual accounts 2024-42,8 k €↓
  3. 2023
    Annual accounts 202310,9 k €↓
  4. 2022
    Annual accounts 202278,8 k €↓
  5. 2021
    Annual accounts 2021108,6 k €↑
  6. 2020
    Annual accounts 202076 k €↑
  7. 2019
    Annual accounts 201943,8 k €↑
  8. 2018
    Annual accounts 201814,9 k €↓
  9. 2017
    Annual accounts 201716,3 k €↓
  10. 2016
    Annual accounts 201629,3 k €↑
  11. 2015
    Annual accounts 201521,9 k €↑
  12. 2014
    Annual accounts 2014-5,7 k €↓
  13. 2013
    Annual accounts 201327,2 k €↑
  14. 2012
    Annual accounts 201224,8 k €↑
  15. 2011
    Annual accounts 201119,9 k €
  16. 18/11/2010
    IncorporationPrivate company with limited liability